Arterial hypertension and renal allograft survival

JAMA

Volumn 283, Issue 5, 2000, Pages 633-638

  Mange, Kevin C ^b   Cizman, Borut ^b   Joffe, Marshall ^b   Feldman, Harold I ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ETHNOLOGY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HEMODIALYSIS; HLA MATCHING; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0034594631     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.5.633     Document Type: Article

References (16)

1. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA. 1993;270:1339-1343.
2. Feldman HI, Fazio I, Roth D, et al. Recipient body size and cadaveric renal allograft survival. J Am Soc Nephrol. 1996;7:151-157.
3. Chertow GM, Milford EL, Mackenzie HS, Brenner BM. Antigen-independent determinants of cadaveric kidney transplant failure. JAMA. 1996;276:1732-1736.
4. Vianello A, Mastrosimone S, Calconi G, Gatti PL, Calzavara P, Maresca MC. The role of hypertension as a damaging factor for kidney grafts under cyclosporine therapy. Am J Kidney Dis. 1993; 21:79-83.
5. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int. 1998;53:217-222.
6. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13-18.
7. Ruggenenti P, Perico N, Mosconi L, et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int. 1993;43:706-711.
8. Chagnac A, Zevin D, Ori Y, Korzets A, Hirsh J, Levi J. The effect of high-dose nifedipine on renal hemodynamics of cyclosporine-treated renal allograft recipients. Transplantation. 1992;53:766-769.
9. Giatras I, Lau J, Levey AS, for the Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Ann Intern Med. 1997;127:337-345.
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31-41.
11. Cox DB. Regression models and life tables. J R Stat Soc. 1972;34:187-202.
12. Lee E. Statistical Methods for Survival Data Analysis. 2nd ed. New York, NY: John Wiley & Sons; 1992.
13. Gramsch PM, Therneau TM. Propotional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
14. Walker WC, Neaton JD, Cutler JA, Neuwirth R, Cohen JD, for the MRFIT Research Group. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: racial and treatment effects. JAMA. 1992;268:3085-3091.
15. Cosio FG, Dillon JJ, Falkenhain ME, et al. Racial differences in renal allograft survival: the role of systemic hypertension. Kidney Int. 1995;47:1136-1141.
16. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet in Renal Disease Study. Ann Intern Med. 1995;123:754-762.